Publications by authors named "Sangmi Ha"

Background: The incidence of type 1 diabetes mellitus (T1DM) among children is high in Europe and the USA and relatively low in Asia, including Korea. The present study aimed to investigate the incidence and prevalence of childhood-onset T1DM in Korea and examine trends in incidence.

Methods: This study was conducted using the national registry data provided by the Health Insurance Review and Assessment Service in Korea from 2007 to 2017.

View Article and Find Full Text PDF

Nontuberculous mycobacteria (NTM) are important pathogens in humans, and hospital-based studies have shown an increased incidence of NTM infection. However, little is known about the treatment pattern of NTM infection with respect to the number of cases per population in South Korea. This study evaluated the trends in the incidence of NTM infection, respiratory comorbidities, and treatment patterns in South Korea.

View Article and Find Full Text PDF

The Electronic Data Interchange (EDI) medical procedure code is the code used for health insurance claims in Korea. We mapped Korean EDI codes to SNOMED CT to explore the global interoperability of health insurance claims data. We developed rules for mapping based on the mapping guideline provided by SNOMED CT International.

View Article and Find Full Text PDF
Article Synopsis
  • The study aimed to analyze the rates of central precocious puberty in Korea using health insurance claims data from 2008 to 2014.
  • A total of 37,890 girls and 1,220 boys were diagnosed, revealing an incidence rate of 122.8 per 100,000, significantly higher in girls (262.8) compared to boys (7.0).
  • Findings indicated a steep rise in both the incidence and prevalence of central precocious puberty during the study period, highlighting the need for further research into its causes.
View Article and Find Full Text PDF

The aim of this study is to assess the actual epidemiologic features of Kawasaki disease (KD) in Korea using the data from Health Insurance Review & Assessment Service (HIRA) claims from 2007 to 2014. We investigated HIRA claims of patients who had KD (International Classification of Diseases-10, M30.3) as a major diagnosis and were given intravenous immunoglobulin (IVIG) from 2007 to 2014.

View Article and Find Full Text PDF